ARS Pharmaceuticals to show new analyses and partner late-breakers on neffy at AAAAI 2026
ARS Pharmaceuticals, Inc. announced that five poster presentations, one healthcare professional (HCP) case report, plus two late breakers from partners at ALK-Abelló A/S (ALK) centered on neffy, will… read more.
